Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 21, 2021 | Kyligence | $70.0M Series D | Hongrui Jia | Alpha Square Group, CICC Capital, Eight Roads Ventures, Gopher Asset Management, Jumbo Sheen Group, Redpoint Ventures, Shanghai Growth Capital, Shunwei Capital |
| Dec 1, 2020 | CANbridge Pharmaceuticals | $43.0M Series E | Cathy Chen | Casdin Capital, Hudson Bay Capital, LYFE Capital, RA Capital Management, Summer Capital, Tigermed, Yali Capital |